This early-stage study is testing a new oral drug called OMX-0407 in adults with advanced solid tumors that cannot be surgically removed and have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors in specific ca…
Phase: PHASE1, PHASE2 • Sponsor: iOmx Therapeutics AG • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC